✦ LIBER ✦

Interferon-induced retinopathy and its risk in patients with diabetes and hypertension undergoing treatment for chronic hepatitis C virus infection

✍ Scribed by J. D. PANETTA; N. GILANI

Book ID: 108605694
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 67 KB
Volume: 30
Category: Article
ISSN: 0269-2813
DOI: 10.1111/j.1365-2036.2009.04071.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Differences Between Interferon-α and-β T

Differences Between Interferon-α and-β Treatment for Patients with Chronic Hepatitis C Virus Infection

✍ Norihiro Furusyo; Jun Hayashi; Misako Ohmiya; Yasunori Sawayama; Yasunobu Kawaka 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 738 KB

Effectiveness of Interferon Treatment fo

Effectiveness of Interferon Treatment for Patients with Chronic Hepatitis C Virus Infection and Normal Aminotransferase Levels

✍ Misako Ohmiya; Jun Hayashi; Kumiko Ueno; Norihiro Furusyo; Yasunori Sawayama; Ya 📂 Article 📅 2000 🏛 Springer US 🌐 English ⚖ 71 KB

Incidence and risk factors of retinopath

Incidence and risk factors of retinopathy in Egyptian patients with chronic hepatitis C virus treated with pegylated interferon plus ribavirin

✍ Yasser M. Fouad; Hanaa Khalaf; Hala Ibraheem; Heba Rady; Amal K. Helmy 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 328 KB

Risk factors for hepatocellular carcinom

Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C

✍ Akinori Kasahara; Norio Hayashi; Kiyoshi Mochizuki; Masahide Takayanagi; Kentaro 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

To elucidate the risk factors for liver carcinogenesis and to examine the incidence of hepatocellular carcinoma (HCC) after interferon therapy, 1,022 chronic hepatitis C patients treated with interferon were followed by ultrasonography for 13 to 97 months (median 36 months). Sustained response with

Treatment of chronic hepatitis C virus i

Treatment of chronic hepatitis C virus infection with pegylated interferon and ribavirin in cirrhotic patients waiting for liver transplantation

✍ B.E. Annicchiarico; M. Siciliano; P. Parente; A. Gasbarrini; G. Bombardieri 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Treatment of Chronic Hepatitis C Virus I

Treatment of Chronic Hepatitis C Virus Infection With Pegylated Interferon and Ribavirin in Cirrhotic Patients Awaiting Liver Transplantation

✍ B.E. Annicchiarico; M. Siciliano; A.W. Avolio; G. Caracciolo; A. Gasbarrini; S. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 55 KB